CHOLANGIO
TODAY
Patient-Led Understanding
Understanding changes what happens next.
Patient-Led investigations into cholangiocarcinoma, cancer biology and the consequential questions that matter when the patient carries the consequence.
LATEST INVESTIGATION
PD-L1 Negative. Still Responds: What Are We Missing? | Cholangio TODAY
PD-L1-negative patients can respond to PD-1 immunotherapy. If the test says negative but the patient responds, what biology did the test fail to capture?
CHOLANGIO TODAY
Earlier Investigations
ATM Mutation in Cancer: What It Means and Why Context Matters
ATM mutation in cancer is often misunderstood. This article explains what ATM really means, why it appears, and why biological context matters more than the gene itself.